Charles River Laboratories to Present at Evercore ISI Investor Conference
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov 27, 2018--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore ISI HealthConX Conference in Boston on Thursday, November 29 th, at 11:00 a.m. ET. Management will present an overview of Charles River’s strategic focus and business developments.
A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for approximately two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005857/en/
CONTACT: Todd Spencer
Corporate Vice President, Investor Relations
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL RESEARCH SCIENCE GENERAL HEALTH
SOURCE: Charles River Laboratories International, Inc.
Copyright Business Wire 2018.
PUB: 11/27/2018 04:46 PM/DISC: 11/27/2018 04:46 PM